PhreeX
Bluelight Crew
http://www.oxycontin.com/pressroom/news/oxycontinNews/purdue_pharma_begins_clinical.htm
"Purdue Pharma L.P. has begun clinical studies of a new pharmaceutical product combining the opioid analgesic oxycodone in a controlled-release formulation with an opioid antagonist, naloxone."
We have our work cut out for us...
